TMCI · NASDAQ · Medical - Devices

Treace Medical Concepts (TMCI)

Builds surgical systems for bunion and related midfoot deformity procedures.

$4.51
vs last close−0.08 (−1.70%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue416251444569534750634745
Cost of revenue811109913111011121010
Gross profit335141363655423840503736
515860575156575555565551
Research & development445555655554
465355524650524950525046
Selling & marketing344040383337363333373431
General & administrative131314141414161616151615
Other expenses000000001000
Operating income−18−7−19−21−150−16−17−16−6−17−15
01000000−1−3−1−1
Interest income222111111110
Interest expense111111111122
Other non-operating income−2−2−2−1−1−1−1−1−12−1−1
Income before tax−18−6−19−21−15−1−16−17−16−9−18−16
Net income from continuing operations−18−6−19−21−15−1−16−17−16−9−18−16
Net income−18−6−19−21−15−1−16−17−16−9−18−16
EPS, basic−$0.28−$0.10−$0.30−$0.34−$0.25−$0.01−$0.25−$0.28−$0.26−$0.15−$0.28−$0.24
EPS, diluted−$0.28−$0.10−$0.30−$0.34−$0.25−$0.01−$0.25−$0.28−$0.26−$0.15−$0.28−$0.24
Weighted average shares, basic626262626262636364646565
Weighted average shares, diluted626262626262636364646565
EBITDA−15−3−15−18−123−12−14−12−5−15−12
Depreciation & amortization222222233312
EBIT−16−5−17−20−141−15−16−15−8−16−14